Key facts
- Notable investors include Misfits (India).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for 101 GenAI
- ·The full record, as it builds
Funding rounds
No funding rounds for 101 GenAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About 101 GenAI
Developer of an artificial intelligence healthcare infrastructure designed for quality and risk management in care delivery. The company offers tools and resources to accelerate the development, validation, and deployment of AI-driven healthcare services, enabling healthcare organizations and innovators to efficiently bring compliant, integrated, and scalable AI applications to market by supporting the unique requirements of the health sector.
- Sector
- Healthcare
- HQ
- Cupertino, CA, United States
- Founded
- 2023
- Employees
- 21
- Website
- 101gen.ai/
- Ownership
- Privately Held (backing)
101 GenAI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 101 GenAI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 101 GenAI in its N-PORT filings yet. We sweep new filings monthly.